Cryoprevention of oral mucositis
Reference number | |
Coordinator | BrainCool AB (publ) |
Funding from Vinnova | SEK 500 000 |
Project duration | November 2016 - November 2018 |
Status | Completed |
Important results from the project
The primary aim is to study patients with myeloma or lymphoma undergoing autologous SCT, to evaluate whether cooling with Cooral compared with ice cubes/crushed ice or ice pop succeeds in reducing the degree of OM according to the Oral Mucositis Assessment Scale, OMAS total.
Expected long term effects
The results are expected following inclusion of a total of 180 patients
Approach and implementation
All measurements, with the exception of the patient’s subjective assessment of the cooling method, will be registered beginning at admission and will continue until discharge or until day +28. Cytostatic infusion generally starts on the day after admission. Grading of OM according to OMAS and WHO is done three times a week. Assessment of the two cooling methods is performed after completion of ice/Cooral cooling in conjunction with cytostatic infusion. Body temperature is registered in the oral cavity in accordance with the department’s routines.